Xianjin Du Selected Research

Xianjin Du Research Topics

Disease

6	Inflammation (Inflammations) 10/2022 - 01/2016
4	Sepsis (Septicemia) 10/2022 - 01/2020
3	Neoplasms (Cancer) 01/2021 - 01/2018
3	Atherosclerosis 12/2020 - 01/2019
2	Pneumonia (Pneumonitis) 01/2020 - 01/2016
2	Staphylococcal Pneumonia 01/2020 - 01/2016
1	Wounds and Injuries (Trauma) 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Reperfusion Injury 01/2021
1	Infections 01/2021
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Ischemia 06/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2014
1	Infarction (Infarctions) 06/2014
1	Fibrosis (Cirrhosis) 06/2010
1	Ureteral Obstruction 06/2010

Drug/Important Bio-Agent (IBA)

5	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2020 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 06/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
2	Apolipoproteins E (ApoE)IBA 12/2020 - 01/2019
2	CytokinesIBA 01/2020 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2020
1	SeleniumIBA 01/2023
1	Explosive Agents (Explosives)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	LipopolysaccharidesIBA 10/2022
1	dicarboxydine (DCD)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 12/2020
1	Interleukin-12 (IL 12)IBA 12/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	oxidized low density lipoproteinIBA 01/2019
1	IronIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	C-Type Lectins (C-Type Lectin)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Surface-Active Agents (Surfactants)IBA 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 06/2014
1	HMGB1 Protein (HMG1)IBA 06/2014
1	Exenatide (Byetta)FDA Link 06/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2014
1	exendin (9-39)IBA 06/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 06/2014
1	Connective Tissue Growth FactorIBA 06/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2021
1	Emergency Treatment 01/2023
1	Ligation 10/2022
1	Punctures 10/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2022
1	Continuous Renal Replacement Therapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Radiotherapy 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2018
1	Subcutaneous Injections 01/2018